Christenberry Kenneth W MD is categorized under Ear Nose and Throat Doctors in Knoxville, TN and active since 1973.
Christenberry Kenneth W MD was established in 1973, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Ear Nose and Throat Doctors business, which does work in the B2C market, and is classified as a Ear Nose and Throat Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Kenneth Christenberry at the company’s single location by writing to 1318 West Clinch Avenue, Knoxville, Tennessee TN 37916 or by phoning (865) 522-5155. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Christenberry Kenneth W MD |
Contact Person: | Kenneth Christenberry |
Address: | 1318 West Clinch Avenue, Knoxville, Tennessee 37916 |
Phone Number: | (865) 522-5155 |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 1973 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Ear Nose and Throat Doctors |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Christenberry Kenneth W MD was started in 1973 to provide professional Ear Nose and Throat Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Kenneth Christenberry for inquiries that concern Christenberry Kenneth W MD by calling the company number (865) 522-5155, as your correspondence is most welcome. Additionally, the physical location of the single location of Christenberry Kenneth W MD can be found at the coordinates 35.96011,-83.92817 as well as the street address 1318 West Clinch Avenue in Knoxville, Tennessee 37916.
For its online presence, you may visit Christenberry Kenneth W MD’s website at and engage with its social media outlets through on Twitter and on Facebook.